Xiamen Red Phase Instruments Inc (300427) fair value: what the stock is really worth
As of Sep 22, 2026: fair value of Xiamen Red Phase Instruments Inc ¥0.62, price ¥6.88, upside -91.0%, quality 50 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Structural break:
The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.
Weakest SetupStrongly overvalued and low quality.
!Fair value ¥0.6205 · Strongly overvalued (−91%)
!Quality 50/100
!Weak Growth(revenue 5y −13.4 %/yr)
!Loss-making · -4.3% net margin (TTM)
✓Low debt · generates free cash flow
!Trails peers(4/13)
!Narrow moat13/100
!Evidence only low, so the estimate is less certain
Watch Xiamen Red Phase Instruments Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Red phase INC., together with its subsidiaries, provides solutions for power grid condition-based maintenance and intelligent operations in China and internationally. It operates through Power Division, New Energy Division, and Communications Division segments.
Show more
Red phase INC., together with its subsidiaries, provides solutions for power grid condition-based maintenance and intelligent operations in China and internationally. It operates through Power Division, New Energy Division, and Communications Division segments. The company offers power grid and generation system application products; RF components; microwave components and communication products; electronic components and electromechanical assembly equipment; communication electronic products; and intelligent infrared thermal imaging systems. It also engages in new energy development, construction, and management consulting; computer software development; sales and technical consulting; investment and financial management; general contracting of power projects and maintenance of power facilities; power generation, transmission, and distribution; construction engineering; design, development, construction, and consulting of solar photovoltaic power generation projects; arms trade; and photovoltaic power generation equipment installation activities. The company was formerly known as Xiamen Red Phase Instruments Inc. and changed its name to Red phase INC. in February 2018. Red phase INC. was incorporated in 2005 and is based in Xiamen, China.
Stock analysis
Xiamen Red Phase Instruments Inc (300427) currently trades at ¥6.88, while our model-based Fair Value estimate is ¥0.6205, implying the stock looks roughly 1,008.6% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ¥2.06 per share, and 0 of the 13 models we run sit above the ¥6.88 price.
Bear case: the Earnings-Based group reads lowest at ¥0.7300, and 13 of the 13 models stay below the price. Evidence for this calculation is low.
Quality & growth
The Quality Score stands at 50/100 (solid quality), in the Industrials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Xiamen Red Phase Instruments Inc reported revenue of 738M CNY in FY2025 versus 1.4B CNY in FY2021, a compound −14.4%/yr. Reported net income was −17.9M CNY in FY2025.
Key figures
Market cap 3.7B CNY (≈ $558M) · P/S ratio 5.13 · EPS (TTM) ¥−0.0600 · Dividend yield 0.0% · Net margin −2.4% · Return on equity −2.5% · Return on assets (EBIT) −9.9% · Operating margin −6.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 62% below its 52-week high and 26% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −36% fair-value upside, at −91%, 300427 screens richer than that median.
Fair Value models
Bear ¥0.6205Fair Value ¥0.6205Bull ¥0.6205
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.24/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+16.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−23.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.4%
Start year 2020 (pandemic). Over 10 years: +9.2% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.5%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
16.7% (2020) → 0.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+31.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about +29.3% a year for the price.
Compare Xiamen Red Phase Instruments Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electrical Equipment & Parts · 550 stocks
Beats the industry median on 3/11 measures
Overall it trails its industry peers.
Valuation
Quality Score50 · Below median
Fair Value upside−91% · Bottom 25%
Profitability
Return on assets−1% · Bottom 25%
Net margin (TTM)−4% · Bottom 25%
Operating margin (TTM)−6% · Bottom 25%
Growth and dividend
Revenue growth1% · Below median
Dividend yield (TTM)0.0% · Bottom 25%
Valuation Multiplesvs Electrical Equipment & Parts median · lower = cheaper
P/B0.47× · Cheapest 25%
P/S (TTM)0.77× · Cheaper than median
P/FCF11.2× · Pricier than median
EV/EBITDA12.3× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)7· sector 58
PAST (return on equity)0· sector 26
HEALTH (low debt)100· sector 97
DIVIDEND (yield)0· sector 23
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Xiamen Red Phase Instruments Inc Fair Value". https://www.fairvalue-calculator.com/stock/300427
Frequently asked questions
Is Xiamen Red Phase Instruments Inc (300427) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ¥0.6205 versus a price of ¥6.88, about −91% upside (overvalued).
What is the fair value of 300427?
Our model-based fair value for Xiamen Red Phase Instruments Inc is ¥0.6205 (as of Sep 24, 2026), built from audited fundamentals. The current price: ¥6.88.
What is the quality score of 300427?
Xiamen Red Phase Instruments Inc has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Xiamen Red Phase Instruments Inc (300427)?
Our model-based price target is the fair value of ¥0.6205 (as of Sep 24, 2026) from 13 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Xiamen Red Phase Instruments Inc stock forecast for 2026?
Our models put fair value at ¥0.6205, about −91% upside versus a price of ¥6.88 (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of Xiamen Red Phase Instruments Inc (300427)?
Xiamen Red Phase Instruments Inc reported trailing-twelve-month revenue of about 729M CNY (latest available figure, as of Sep 24, 2026).
Does Xiamen Red Phase Instruments Inc pay a dividend?
Xiamen Red Phase Instruments Inc currently shows a dividend yield of about 0.02% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Xiamen Red Phase Instruments Inc (300427)?
For today's price to be fair in a discounted-cash-flow model, Xiamen Red Phase Instruments Inc would have to grow free cash flow by +31.5 % per year for five years (discount rate 10.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -13.4 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 300427 use?
Our models discount Xiamen Red Phase Instruments Inc at 10.4 %: a base by market capitalisation (small), damped by beta 0.30, country premium for China. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Xiamen Red Phase Instruments Inc that is +31.5 % per year a year over ten years, using the same discount rate (10.4 %) and the same formula as our fair value.
How much growth has Xiamen Red Phase Instruments Inc (300427) delivered so far?
Over the past 5 years revenue at Xiamen Red Phase Instruments Inc grew -13.4 % a year. The price currently implies +31.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Xiamen Red Phase Instruments Inc (300427) growing?
The median revenue growth in the sector is +8.2 % a year. That is the yardstick for the growth priced into Xiamen Red Phase Instruments Inc (+31.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Xiamen Red Phase Instruments Inc (300427)?
The free-cash-flow yield on the price is 1.62 %: that much free cash flow Xiamen Red Phase Instruments Inc produces per unit of market value. When it exceeds the discount rate of our models (10.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Xiamen Red Phase Instruments Inc (300427)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Xiamen Red Phase Instruments Inc it is ¥0.6205 per share (as of Sep 24, 2026), against a price of ¥6.88. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is Xiamen Red Phase Instruments Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 300427 trades above its calculated fair value: price ¥6.88, fair value ¥0.6205, a gap of about −91% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 300427?
No. The price is what the market pays today (¥6.88); the fair value is what the company's own numbers justify (¥0.6205). For Xiamen Red Phase Instruments Inc the two are ¥6.26 per share apart. That gap is exactly why we show both numbers side by side.
How much is Xiamen Red Phase Instruments Inc worth?
The market values Xiamen Red Phase Instruments Inc at about 3.7B CNY (market capitalisation, as of Sep 24, 2026). Per share that is ¥6.88; our models calculate a fair value of ¥0.6205 per share.
How solid is the balance sheet of Xiamen Red Phase Instruments Inc (300427)?
Balance-sheet figures for Xiamen Red Phase Instruments Inc (as of Sep 24, 2026): return on equity −2.5%. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
How far is 300427 from its 52-week high?
Xiamen Red Phase Instruments Inc trades at ¥6.88, about 62% below its 52-week high of ¥18.11 and 26% above the low of ¥5.44 (as of Sep 22, 2026). Distance from the high says nothing about value: that is what the fair value of ¥0.6205 is for.
Which stocks are comparable to Xiamen Red Phase Instruments Inc?
From the same area (Industrials) we also value Contemporary Amperex Technology Co, ABB Ltd, Delta Electronics (Thailand) Public Company, Vertiv Holdings, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Xiamen Red Phase Instruments Inc stock attractive at the current price?
The data as of Sep 24, 2026: price ¥6.88, calculated fair value ¥0.6205 (−91%), Quality Score 50/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 300427 calculated?
We run Xiamen Red Phase Instruments Inc through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥0.6205, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Xiamen Red Phase Instruments Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Xiamen Red Phase Instruments Inc (300427)?
The closing price on Sep 22, 2026 was ¥6.88. Our model-based fair value is ¥0.6205, about −91% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Xiamen Red Phase Instruments Inc right now?
The price sits above even our optimistic bull case (¥0.6205). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Xiamen Red Phase Instruments Inc
How large is the market capitalisation of Xiamen Red Phase Instruments Inc (300427)?
The market capitalisation of Xiamen Red Phase Instruments Inc is 3.7B CNY (≈ $558M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Xiamen Red Phase Instruments Inc (300427)?
The price-to-sales ratio of Xiamen Red Phase Instruments Inc is 5.13 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Xiamen Red Phase Instruments Inc (300427)?
Earnings per share at Xiamen Red Phase Instruments Inc are ¥−0.0600. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Xiamen Red Phase Instruments Inc (300427)?
The dividend yield of Xiamen Red Phase Instruments Inc is 0.0%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Xiamen Red Phase Instruments Inc (300427)?
The net margin of Xiamen Red Phase Instruments Inc is −2.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Xiamen Red Phase Instruments Inc (300427)?
The return on equity (ROE) of Xiamen Red Phase Instruments Inc is −2.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Xiamen Red Phase Instruments Inc (300427)?
On an EBIT basis the return on assets of Xiamen Red Phase Instruments Inc is −9.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Xiamen Red Phase Instruments Inc (300427)?
The operating margin of Xiamen Red Phase Instruments Inc is −6.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Xiamen Red Phase Instruments Inc (300427)?
Revenue at Xiamen Red Phase Instruments Inc is growing +1.4% versus a year earlier (3y avg −23.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Xiamen Red Phase Instruments Inc (300427)?
Earnings per share at Xiamen Red Phase Instruments Inc are growing −77.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Xiamen Red Phase Instruments Inc (300427) hold?
Xiamen Red Phase Instruments Inc holds more cash than debt, 239M CNY net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Xiamen Red Phase Instruments Inc in the live analysis
One click puts Xiamen Red Phase Instruments Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
